Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes: A Multi-center, Randomized Controlled Trial

NCT00211510 is registered in ClinicalTrials.gov with Medtronic MiniMed, Inc. as lead sponsor.

NCT NCT00211510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00211510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes: A Multi-center, Randomized Controlled Trial
Lead sponsor
Medtronic MiniMed, Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2005
Completion date
February 28, 2007
Enrollment
146 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes